Cingulate Inc. (CING:NASDAQ) rocketted at $1.79, a gain of 31.6%. On Tue, Mar 15, 2022, CING:NASDAQ hit a New 2-Week High of $1.43. The stock appeared on our News Catalysts scanner on Thu, Mar 10, 2022 at 08:00 AM in the 'BIOTECH' category. From Wed, Mar 02, 2022, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Mon, Jan 03, 2022 at $3.14 with a volume of 1M+.
About Cingulate Inc. (CING:NASDAQ)
Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical...
Top 10 Gainers:
- Kidpik Corp. (PIK:NASDAQ), 158.15%
- Marrone Bio Innovations, Inc. (MBII:NASDAQ), 49.7%
- TC BioPharm (Holdings) plc (TCBP:NASDAQ), 45%
- Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ), 40.25%
- Mullen Automotive Inc. (MULN:NASDAQ), 39.43%
- Synthetic Biologics, Inc. (SYN:NYSEMKT), 37.56%
- Orphazyme A/S (ORPH:NASDAQ), 37.4%
- Innodata Inc. (INOD:NASDAQ), 34.33%
- Neonode Inc. (NEON:NASDAQ), 33.02%
- Cingulate Inc. (CING:NASDAQ), 31.62%